Liver surgeon with focus on minimally invasive techniques and living donation
Joined June 2019
- Tweets250
- Following439
- Followers674
- Likes1.5K
Ben Samstein retweeted
Double kidney and liver transplant recipient Nercy Sullivan spoke with the @weillcornell community today about the importance of organ donation in honor of #NationalDonateLife Blue & Green Day 💙💚
@AlchemySpace @DBrandmanMD @WCMDeptofMed
Ben Samstein retweeted
One year ago, our first fully robotic liver transplant marked an important milestone.
Since then:
• 15 fully 🤖 LTs (12 LDLTs)
• 6 hybrid 🤖 LDLTs
• 44 🤖 donor hepatectomies
• 400+ 🤖 liver cases
From scattered robotic practice to a programmatic approach since 2022.
Now consistently performing fully robotic LDLT with simultaneous donor + recipient teams.
A program built step by step, and a team that makes it work.
#LiverTransplantation #RoboticSurgery #iLDLT
Ben Samstein retweeted
When Vicky needed a liver transplant, her friend Zoë donated part of hers. 💚
Thanks to expert care at @nyphospital, @weillcornell & Drs. @juampirocca and @BenSamstein, their journey became a success. Now they’re raising awareness. You can help: 🔗engdr.co/6-302904
Ben Samstein retweeted
This week at NYP/Weill Cornell we completed our 3rd robotic liver transplant, this time using a right lobe living donor graft.
Amazing team effort running 2 simultaneous robotic rooms for donor and recipient.
Ben Samstein retweeted
This Mother’s Day, celebrate chosen family and second chances! Watch Chrissy and Page's story: youtube.com/watch?v=X5jdRr9e… @BenSamstein @WEILLCORNELL @NYPHospital Learn about Living Donor Liver Transplantation: bit.ly/38K31C0
Ben Samstein retweeted
🚨Register and log in for this important conversation led by @Julius__Wilder and #LornaDove. Moderated by @AnugwomChimaobi. Tuesday at noon eastern.
aasld.org/webinar-celebratin…
Join us on February 6th for this eye-opening webinar! Register now and be part of the conversation. aasld.org/webinar-celebratin…
@AnugwomChimaobi
@Julius__Wilder
#LiverTwitter
Ben Samstein retweeted
🆕🗞️Just out
🪺#NEST-1 trial results👇🏾
Are we on the verge of a new drug combo for colon or rectal cancer?
Substantial & brisk responses to just☝🏾dose of BOT🟢➕BAL🔹🔹 immunotherapy.🙌🏾
Pattern & kill is unprecedented🌊.
@ASCO #GI24 @OncoAlert
Abstract 117📍Poster Board H2
Ben Samstein retweeted
Embracing a "robotic-preferred approach" in 2022 significantly changed our division's practice of liver surgery and transplantation during 2023, expanding MIS benefits to complex hepatectomies, donor hepatectomies, and hepatectomy during transplantation.
Ben Samstein retweeted
Our Surgery Pipeline Program is accepting applications! This virtual program exposes students to life as a surgeon and tips for applying to medical school. Link to apply: bit.ly/3NeVBrF
@LANewmanMD @minervies @DrBeaMD
@WCMDiversityCtr @SNMA_MAPS
@AmCollSurgeons
Ben Samstein retweeted
Are u a GI fellow who is #hepcurious? Planning on applying to tx hep fellowship next year? Do u just want to chat with some cool hepatologists? Join the NYP Tx Hep team for coffee at #TLM on Sat @ 3pm or Sun @ 10am at Blue Bottle Coffee! #livertwitter #GITwitter @LiverFellow
Ben Samstein retweeted
Up to 70% of people with type 2 diabetes have #NAFLD. On #NYPAdvances, @DBrandmanMD discusses how screening through primary care providers can help detect patients at high risk for fatty liver disease.
nyphosp.co/3S4v9Eg
@ColumbiaMed, @WeillCornell #ThinkLiverThinkLife
Ben Samstein retweeted
Congratulations to the Weill Cornell Medicine Surgery Chief of Breast Surgery on being elected to the National Academy of Medicine!
Click here to read more: news.weill.cornell.edu/news/…
Ben Samstein retweeted
Join us in congratulating the #NYP Center for Liver Disease and Transplantation on achieving the milestone of performing their 500th pediatric liver #transplant. 👏 Learn more: nyphosp.co/3F9DOh7 @ColumbiaMed, @WeillCornell
Ben Samstein retweeted
Two years since Liver Transplant still going strong! Bear Mountain Couldn’t have done it without the Greatest Doctors in the world Dr. Russell Rosenblatt @rrosenblattmd and Dr. Karim Halazun @theliversurgeon and their team at Cornell Medical Center @WeillCornell Forever Grateful
Ben Samstein retweeted
Love starting @ATCMeeting engaging with COP chairs and the board to improve @AST_info mission. Thank you @dktransplant for hosting and always love spending time with one of my absolute favorites @VineetaKumar8 @AST_LICOP
Ben Samstein retweeted
Great to see this! Looking forward to more of the details as this is a heterogeneous population including PVTT. Either way- systemic therapy (NEO and ADJ) seems poised to ⬆️⬆️ the population of #HCC patients who may benefit from surgical resection.
#IMBRAVE050 results #AACR23:
#AtezoBev (x12m) improves RFS (HR 0.72 (95%CI 0.56-0.92) in HIGH-RISK #resected #HCC
➡️Definition of high risk 📝
➡️VHB+ve 62%
➡️RFS curve overlaps at 21m -🤔 treatment duration?
➡️Pending mature OS data
➡️<2% G5 tox
Great discussion #StephenChan 👏🏻
Ben Samstein retweeted
Professor Jean Emond of @ColumbiaSurgery discussing surgical and interventional options for SFSS. ILTS-iLDLT-LTSI 2023 Consensus Conference in #Chennai @Rela_Institute #ILTS #iDLT #LTSI 2023 #consensus #MCLDCongress
Ben Samstein retweeted
Congrats to our @WCMEnglanderIPM colleagues Dr. Pashtoon Kasi (@pashtoonkasi), our Director for Liquid Biopsy Research (left), and Dr. Scott T. Tagawa (@DrScottTagawa) on accruing the most #WCM patients to therapeutic & non-therapeutic studies in Dec. 2022, with @WCM_MeyerCancer!
Ben Samstein retweeted
UNOS has launched the UNOS Liver Paired Donation pilot program, the first nationwide initiative facilitating LPD matches. This innovative approach aims to increase lifesaving transplants by expanding the number of living #liver donations. #DonateLife unos.org/news/unos-labs-live…
Ben Samstein retweeted
⚡️ On @NatureMedicine - Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
@montypal @NazliDizman #kidneycancer #immunotherapy
nature.com/articles/s41591-0…
